Got­tlieb tes­ti­fies on sta­tus of FDA op­er­a­tions af­ter gov­ern­ment shut­down

FDA Com­mis­sion­er Scott Got­tlieb tes­ti­fied be­fore the House Com­mit­tee on Ap­pro­pri­a­tions Wednes­day on the cur­rent state of agency ac­tiv­i­ties. Got­tlieb ex­pressed con­fi­dence that the agency is “back on track,” de­spite the 35-day lapse in FDA ap­pro­pri­a­tions dur­ing the longest par­tial gov­ern­ment shut­down in US his­to­ry.

Mem­bers of the sub­com­mit­tee on agri­cul­ture, rur­al de­vel­op­ment, FDA and re­lat­ed agen­cies ques­tioned Got­tlieb on the sta­tus of the agency’s op­er­a­tions, par­tic­u­lar­ly re­gard­ing ef­forts to mit­i­gate the im­pact of the gov­ern­ment shut­down. They point­ed to FDA’s in­spec­tion­al work of med­ical prod­uct man­u­fac­tur­ing fa­cil­i­ties and re­serve of in­dus­try user fees as ar­eas of con­cern.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.